Posted by desolationrower on December 12, 2008, at 23:16:49
In reply to Eplivanserin - new sleep med, posted by Netch on December 12, 2008, at 11:22:42
> Eplivanserin is the furthest along in development of a new nonsedating drug class known as ASTARs, or Antagonists of Serotonin Two A Receptors. Many sleep disorder experts expect the ASTARs to take over a major chunk of the insomnia treatment market now dominated by zolpidem and other drugs acting on the γ-aminobutyric acid-A receptor, said Mr. Gervais, a pharmacist at Q&T Research of Sherbrooke, Quebec, an independent clinical research firm hired by Sanofi-Aventis to participate in an eplivanserin trial.ASTARs? I would like to punch the Advanced Sales Strategy for Marketing Ugly Names for Corporate Headquarters who came up with ASTARs. Almost as bad as NaSSA and reuptake inhibitors naming mess.
At any rate, its nice a clean drug like this may become availible, and hopefully replaces most of the offlabel use of neuroleptics. Still, many docs can't do polypharmacy so i expect it to be underutilised.
-d/r
poster:desolationrower
thread:868280
URL: http://www.dr-bob.org/babble/20081204/msgs/868401.html